GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers

GDRX 10.16.2024

Full Press ReleaseSEC FilingsOur GDRX Tweets

About Gravity Analytica

Recent News

  • 01.22.2025 - Scott Wagner Joins GoodRx Board of Directors
  • 01.21.2025 - Steven Valiquette
  • 01.15.2025 - Wendy Barnes

Recent Filings

  • 01.22.2025 - 8-K Current report
  • 01.15.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.08.2025 - 3 Initial statement of beneficial ownership of securities
PDF Version

Approved users will now be able to select an Affirm payment plan for select medications directly on theGoodRxplatform

SAN FRANCISCO--(BUSINESS WIRE)--Oct. 16, 2024--GoodRx(NASDAQ: GDRX), the leading prescription savings platform in theU.S., today announced consumers will soon be able to use Affirm to pay over time for select medications at participating retail pharmacies. This adds a convenient way for consumers to pay for their medications directly on theGoodRxplatform.

GoodRxis launching this program with its partner pharmacies, including Hy-Vee, a grocery retailer with a network of more than 275 retail pharmacies. Together, the companies are ensuring a seamless ecommerce experience for consumers. As an example, when a person types their medication intoGoodRxand selects Hy-Vee as their preferred pharmacy, the system will validate their prescription, check for medication inventory, and show the option to pay over time with Affirm. If approved, consumers will be able to choose from customized monthly payment options before submitting their prescription order and picking up their prescription at their local Hy-Vee location.

As is always true with Affirm, consumers will only be approved for financing Affirm believes can and will be repaid responsibly, and Affirm will not charge any late or hidden fees.

“We are always looking for new ways to bring affordability and ease-of-use to patients, doctors and front-line pharmacy staff,” saidScott Wagner, Interim CEO atGoodRx. “Through this new technology solution, we’re offering a unique capability that will help people access their medications - whether it’s helping them reach a deductible or providing great financial flexibility and control. It’s part of our broader e-commerce strategy to make the entire process much simpler, certainly for patients but also for retail pharmacies.”

“As a provider, we are excited to work withGoodRxto offer this new payment solution toHy-Vee Pharmacypatients as we continue efforts to remove healthcare barriers and improve medication adherence,” saidAngie Nelson, Hy-Vee’s senior vice president of pharmacy. “We believe that this new flexible payment model offered throughGoodRxwill lead to better health outcomes for our patients.”

This program will start rolling out in the coming months.

AboutGoodRx

GoodRxis the leading prescription savings platform in theU.S.Trusted by more than 25 million consumers and 750,000 healthcare professionals annually,GoodRxprovides access to savings and affordability options for generic and brand-name medications at more than 70,000 pharmacies nationwide, as well as comprehensive healthcare research and information. Since 2011,GoodRxhas helped consumers save over$75 billionon the cost of their prescriptions.

​GoodRx periodically posts information that may be important to investors on its investor relations website athttps://investors.goodrx.com. We intend to use our website as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with theSecurities and Exchange Commission(the “SEC”) and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.

GoodRx Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the demand and plans for, and the objectives, benefits and value of, theGoodRxand Affirm partnership, including its availability at Hy-Vee. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause GoodRx’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to GoodRx’s ability to achieve broad market education and change consumer purchasing habits, changes in medication pricing and pricing structures, GoodRx’s reliance on a limited number of industry participants, and the important factors discussed in the section entitled “Risk Factors” in GoodRx’s Annual Report on Form 10-K for the year endedDecember 31, 2023, and GoodRx’s other filings with theSecurities and Exchange Commission. Any such forward-looking statements are based on current expectations, projections and estimates as of the date of this press release. WhileGoodRxmay elect to update such forward-looking statements at some point in the future,GoodRxdisclaims any obligation to do so, even if subsequent events cause GoodRx’s views to change.

Payment options through Affirm are subject to eligibility, and are provided by these lending partners:affirm.com/lenders. CA residents: Loans byAffirm Loan Services, LLCare made or arranged pursuant to California Finance Law license 60DBO-111681.

View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241016971099/en/

Press ContactsGoodRxpress@goodrx.com

Source:GoodRx

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com